AZACITIDINE SANDOZ azacitidine 100 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

azacitidine sandoz azacitidine 100 mg powder for injection vial

sandoz pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine is indicated for the treatment of patients with: ? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ? chronic myelomonocytic leukemia [cmmol (10%-29% marrow blasts without myeloproliferative disorder)], ? acute myeloid leukemia (aml) with 20-30% blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

AZACITIDINE MSN azacitidine 100 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

azacitidine msn azacitidine 100 mg powder for injection vial

juno pharmaceuticals pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine is indicated for the treatment of patients with: ? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ? chronic myelomonocytic leukemia [cmmol (10%-29% marrow blasts without myeloproliferative disorder)], ? acute myeloid leukemia (aml) with 20-30% blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

OZVIR Aciclovir 200mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

ozvir aciclovir 200mg tablet blister pack

sun pharma anz pty ltd - aciclovir, quantity: 200 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica - aciclovir tablets are indicated for use in adult patients for: (1) the treatment of first episode (primary or non-primary) genital herpes and the management of recurrent episodes of genital herpes in certain patients. (2) the treatment of acute attacks of herpes zoster (shingles) when the duration of rash is less than 72 hours. (3) the management of patients with advanced symptomatic hiv disease (cd4 + counts < 150 x 10(6)/l). in accordance with details specified in the "indications" and the "dosage and adminsitration" sections of the approved product information provided as attachment 1.

Paracetamol-AFT paracetamol 1000 mg/100 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol-aft paracetamol 1000 mg/100 ml injection vial

aft pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; cysteine hydrochloride monohydrate; dibasic sodium phosphate dihydrate; mannitol; nitrogen; water for injections; sodium hydroxide - paracetamol-aft 10mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Pro Vitality Australia - English - Department of Health (Therapeutic Goods Administration)

pro vitality

gnld international pty ltd - capsicum annuum,carrot seed oil,d-alpha-tocopherol,fish oil - rich in omega-3 acids,fragaria vesca,glycine max,lycopersicon esculentum,oryza sativa,prunus armeniaca,prunus persica,spinacia oleracea,tocopherols concentrate - mixed (high-alpha -

Siguent Hycor 1% Australia - English - Department of Health (Therapeutic Goods Administration)

siguent hycor 1%

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - eye ointment - excipient ingredients: white soft paraffin; liquid paraffin; wool fat - inflammatory conditions of the eye, including allergic conjunctivitis, nonpurulent conjunctivitis and/or blepharitis, iritis, herpes zoster ophthalmicus, recurrent marginal ulceration.